School Inner City Air Study
Massachusetts General Hospital · with Boston Children's Hospital, National Institute of Allergy and Infectious Diseases (NIAID) · NCT05953233
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 6–90 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 200
- US sites recruiting
- 1
- Study start
- September 15, 2024
- Record last updated
- December 11, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this randomized clinical trial is to test the efficacy of high efficiency particulate air (HEPA) cleaners in reducing respiratory viral exposure and infections in elementary school classrooms. Classrooms will be randomized to active vs. sham HEPA cleaners. The main questions it aims to answer are:
- Do classroom HEPA cleaners reduce exposure to viruses?
- Do classroom HEPA cleaners reduce student and teacher infections?
- Do classroom HEPA cleaners reduce infections in family members?
Being studied: Active classroom HEPA cleaner; Sham classroom HEPA cleaner
Conditions: Viral Infection
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
Children
- Grades K-5 (age 6-12 years)
- Attend one of the schools that the study team has permission to obtain classroom/school environmental samples
- Have no plans to move schools within the upcoming 12 months
- Subject and/or parent guardian must be able to understand and provide informed consent and also willing to participate in the study
Adults
- Adult (age 21 or older) parent, caretaker, or household member of child participating in this study, or teacher in classroom participating in study
- Able to understand and provide informed consent
Exclusion Criteria
Children
- Contraindication to or inability to participate in home self-collection of nasal swab samples
- Severe chronic diseases (e.g. cancer, genetic or congenital disorders interfering with mobility)
- Severe neurobehavioral, neurodevelopmental or psychiatric disorders requiring special assistance
- Families who do not speak English or Spanish well enough to complete the survey questions, as validated versions in other languages are not available for all of the measures
Adults
- Contraindication to or inability to participate in home self-collection of nasal swab samples
- Severe chronic diseases (e.g. cancer, genetic or congenital disorders interfering with mobility)
- Severe neurobehavioral, neurodevelopmental or psychiatric disorders requiring special assistance
- Families who do not speak English or Spanish well enough to complete the survey questions, as validated versions in other languages are not available for all of the measures
Recruiting US locations
Mass General Brigham
Boston, MA 02114
Site contact: Peggy Lai, MD MPH
Study contacts (from the official record)
- Peggy Lai, MD MPH · 617-875-9878 · plai@mgh.harvard.edu
- Wanda Phipatanakul, MD MS · 857-218-5336 · wanda.phipatanakul@childrens.harvard.edu
Similar studies in Massachusetts
All healthy volunteers studies in Massachusetts →- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Boston, MA + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1
Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy
Mabylon AG
- Location
- Boston, MA + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1
Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HTX-001
Haya Therapeutics, Inc.
- Location
- Boston, MA + 1 other US site
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Boston, MA + 49 other US sites
- Eligibility basics
- Ages 60+